Addressing the psychosocial aspects of transition to adult care in patients with cystinosis
-
Published:2024-03-22
Issue:10
Volume:39
Page:2861-2874
-
ISSN:0931-041X
-
Container-title:Pediatric Nephrology
-
language:en
-
Short-container-title:Pediatr Nephrol
Author:
Stabouli StellaORCID, Sommer Anna, Kraft Stefanie, Schweer Katharina, Bethe Dirk, Bertholet-Thomas Aurelia, Batte Suzanne, Ariceta Gema, Brengmann Sandra, Bacchetta Justine, Emma Francesco, Levtchenko Elena, Topaloglu Rezan, Willem Lore, Haffner Dieter, Oh Jun
Abstract
AbstractCystinosis is a rare autosomal-recessive lysosomal storage disease that progressively affects multiple organs beginning with the kidneys. Patients require lifelong multidisciplinary care for the management of kidney disease and progressive extra-renal manifestations, and thus, they are especially fragile and vulnerable during transition from pediatric to adult care. Previous documents have provided guidance to help the medical transition of these highly burdened patients. Patients and their families often experience great psychological distress and face significant social challenges; for these reasons, they often need help from psychologists, social workers, and other psychosocial professionals. Due to the rarity of the disease, most psychosocial professionals have no expertise in this disorder and require advice. To this end, a steering committee (SC) composed of six experts, including pediatric nephrologists, psychologists, and social workers with experience in the care for patients with cystinosis, have identified and addressed seven key questions related to psychosocial challenges of the disease and the burden of treatment. Ten additional international experts (the extended faculty, EF) were invited to answer these questions. Since robust evidence is lacking, as in many rare diseases, conclusions were based on collective agreement between members of the SC and the EF, and the consolidated answers were summarized into expert opinion statements. The present document contains information on the concerns and psychosocial burden of patients with cystinosis and of their caregivers, and provides practical advice for timely and appropriate support to facilitate the transition to adult care.
Graphical abstract
Funder
Chiesi Farmaceutici Aristotle University of Thessaloniki
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Emma F, Nesterova G, Langman C, Labbé A, Cherqui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E, Dohil R, Trauner D, Antignac C, Cochat P, Kaskel F, Servais A, Wühl E, Niaudet P, Van’t Hoff W, Gahl W, Levtchenko E (2014) Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant 29(Suppl 4):iv87-94 2. Cherqui S, Courtoy PJ (2017) The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives. Nat Rev Nephrol 13:115–131 3. Levtchenko E, Servais A, Hulton SA, Ariceta G, Emma F, Game DS, Lange K, Lapatto R, Liang H, Sberro-Soussan R, Topaloglu R, Das AM, Webb NJA, Wanner C (2022) Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients. Clin Kidney J 15:1675–1684 4. Ariceta G, Camacho JA, Fernández-Obispo M, Fernández-Polo A, Gámez J, García-Villoria J, Lara E, Leyes P, Martín-Begué N, Perelló M, Pintos-Morell G, Torra R, Torregrosa JV, Torres-Sierra S, Vila-Santandreu A, Güell A (2016) A coordinated transition model for patients with cystinosis: from pediatrics to adult care. Nefrologia 36:616–630 5. Reda A, Veys K, Kadam P, Taranta A, Rega LR, Goffredo BM, Camps C, Besouw M, Cyr D, Albersen M, Spiessens C, de Wever L, Hamer R, Janssen MCH, D’Hauwers K, Wetzels A, Monnens L, van den Heuvel L, Goossens E, Levtchenko E (2021) Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testis. J Inherit Metab Dis 44:1393–1408
|
|